Cargando…
Identification and Validation of STAT6 as a Prognostic and Predictive Biomarker in Acute Myeloid Leukemia
BACKGROUND: Acute myeloid leukemia (AML) is one of the most common hematological diseases in adults. The overall survival rate remains unsatisfactory. It is urgent to identify potential prognostic biomarkers and develop new molecular therapeutic strategies for AML. Signal transducer and activator of...
Autores principales: | Liu, Wei, Zhu, Feiyue, Yan, Jiazhuo, Liu, Yi, Chen, Cong, Zhang, Kaixuan, Zhao, Xielan, Chen, Jingyuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7648156/ https://www.ncbi.nlm.nih.gov/pubmed/33173308 http://dx.doi.org/10.2147/OTT.S272757 |
Ejemplares similares
-
CDK6 Is a Potential Prognostic Biomarker in Acute Myeloid Leukemia
por: Liu, Wei, et al.
Publicado: (2021) -
Identification of the 7-lncRNA Signature as a Prognostic Biomarker for Acute Myeloid Leukemia
por: Liu, Chun-yu, et al.
Publicado: (2021) -
Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia
por: Huang, Rui, et al.
Publicado: (2017) -
Identification of RHOBTB2 aberration as an independent prognostic indicator in acute myeloid leukemia
por: Liu, Peng, et al.
Publicado: (2021) -
Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia
por: Shi, Lingling, et al.
Publicado: (2021)